Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Spero Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2013 · IPO 2017 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$109M
Market cap · Apr/2026
Revenue
$60M
Latest reported FY

Investors

11 investors on Spero Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 2 investors entered at this stage
Atlas Peak Capital
Atlas Venture
Series A 5 investors entered at this stage
Lundbeckfonden
Lundbeckfonden Ventures
Partners Innovation Fund
The Kraft Group
SR One
Series B+ 4 investors entered at this stage
Rock Springs Capital
GV
Osage University Partners
RA Capital Management

Global footprint

Where Spero Therapeutics has talent and traffic

Web traffic by country
3.1K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

See Spero Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo